Choose the experimental features you want to try

This document is an excerpt from the EUR-Lex website

Document 62015TN0312

    Case T-312/15: Action brought on 9 June 2015 — Market Watch v OHIM — Glaxo Group (MITOCHRON)

    OJ C 270, 17.8.2015, p. 37–38 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

    20150731063617142015/C 270/473122015TC27020150817EN01ENINFO_JUDICIAL20150609373822

    Case T-312/15: Action brought on 9 June 2015 — Market Watch v OHIM — Glaxo Group (MITOCHRON)

    Top

    C2702015EN3720120150609EN0047372382

    Action brought on 9 June 2015 — Market Watch v OHIM — Glaxo Group (MITOCHRON)

    (Case T-312/15)

    2015/C 270/47Language in which the application was lodged: English

    Parties

    Applicant: Market Watch Franchise & Consulting, Inc. (Freeport, Bahamas) (represented by: J. Korab, lawyer)

    Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs) (OHIM)

    Other party to the proceedings before the Board of Appeal: Glaxo Group Ltd (Brentford, United Kingdom)

    Details of the proceedings before OHIM

    Applicant: Applicant

    Trade mark at issue: Community word mark ‘MITOCHRON’ — Application for registration No 11 200 078

    Procedure before OHIM: Opposition proceedings

    Contested decision: Decision of the Second Board of Appeal of OHIM of 20 March 2015 in Case R 507/2014-2

    Form of order sought

    The applicant claims that the Court should:

    admit the complaint;

    annul the contested decision and dismiss in its entirety the application filed by the other party to the proceedings before the Board of Appeal;

    order OHIM to pay the costs.

    Plea in law

    The trade marks involved in the dispute are not so similar as to be capable of being confused.

    Top